CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Common Shares to be Issued [Member]	Accumulated Deficit [Member]	Total
Balance Beginning at Sep. 30, 2013	$ 9,309	$ 38,672,452	$ 60,000	$ (41,204,972)	$ (2,463,211)
Balance Beginning (in shares) at Sep. 30, 2013	9,309,400
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity units issued under Purchase Agreement	$ 100	188,070			$ 188,170
Equity units issued under Purchase Agreement (in shares)	100,000
Commitment shares issued under terms of Purchase Agreement	$ 1	(1)
Commitment shares issued under terms of Purchase Agreement (in shares)	628
Capital stock issued for cash - at $2.00	$ 30	59,970	$ (60,000)
Capital stock issued for cash - at $2.00 (in shares)	30,000
Capital stock issued for cash - at $1.20	$ 125	149,875	$ 30,000		$ 180,000
Capital stock issued for cash - at $1.20 (in shares)	125,000
Capital stock issued pursuant to debt conversions - at $1.00	$ 640	550,480			$ 551,120
Capital stock issued pursuant to debt conversions - at $1.00 (in shares)	640,428				640,428
Share issue costs, net of recovery		(2,452)			$ (2,452)
Issuance of detachable warrants		5,989,900			5,989,900
Agent's warrants issued in connection with convertible debentures		334,900			334,900
Beneficial conversion feature on convertible debentures issued, net of deferred income tax		2,610,100			2,610,100
Reclassification of derivative financial instruments upon modification of warrant terms		221,000			221,000
Capital stock issued pursuant to debt conversions - at $1.20	$ 1,595	1,911,932			1,913,527
Capital stock issued pursuant to debt conversions - at $1.20 (in shares)	1,594,607
Stock based compensation		$ 27,925	$ 610,000		637,925
Net loss for the period				$ (9,968,353)	(9,968,353)
Balance Ending at Sep. 30, 2014	$ 11,800	$ 50,714,151	$ 640,000	$ (51,173,325)	$ 192,626
Balance Ending (in shares) at Sep. 30, 2014	11,800,063				11,800,063
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity units issued under Purchase Agreement	$ 1,825	8,125,440			$ 8,127,265
Equity units issued under Purchase Agreement (in shares)	1,825,000
Commitment shares issued under terms of Purchase Agreement	$ 27	(27)
Commitment shares issued under terms of Purchase Agreement (in shares)	27,144
Capital stock issued pursuant to debt conversions - at $1.00	$ 7,272	6,587,850	$ 167,415		$ 6,762,537
Capital stock issued pursuant to debt conversions - at $1.00 (in shares)	7,272,487
Capital stock issued for cash - at $1.00	$ 500	1,500			$ 2,000
Capital stock issued for cash - at $1.00 (in shares)	500,000
Capital stock issued pursuant to subscriptions received - at $1.20	$ 25	29,975	$ (30,000)
Capital stock issued pursuant to subscriptions received - at $1.20 (in shares)	25,000
Shares issued pursuant to the exercise of warrants - at $1.20	$ 3,097	3,713,629			$ 3,716,726
Shares issued pursuant to the exercise of warrants - at $1.20 (in shares)	3,097,275
Shares issued pursuant to the exercise of warrants - cashless	$ 6,839	(6,839)
Shares issued pursuant to the exercise of warrants - cashless (in shares)	6,838,632
Shares issued pursuant to favored nations provision	$ 659	(659)
Shares issued pursuant to favored nations provision (in shares)	658,612
Reclassification of derivative liability		4,482,000			$ 4,482,000
Stock based compensation		$ 413,979	$ 1,220,000		1,633,979
Net loss for the period				$ (12,108,130)	(12,108,130)
Balance Ending at Sep. 30, 2015	$ 32,044	$ 74,060,999	$ 1,997,415	$ (63,281,455)	$ 12,809,003
Balance Ending (in shares) at Sep. 30, 2015	32,044,213				32,044,213